Biochemical assessment of metabolic associated fatty liver disease
Metabolic-associated fatty liver disease (MAFLD) is defined as fat accumulation in the liver in the presence of metabolic alterations. This disorder is generally asymptomatic and may progress to severe liver disease, which are linked to inflammation and/or fibrosis. MAFLD has a high prevalence (26%)...
Enregistré dans:
Auteurs principaux: | Guerra-Ruiz Armando R., Casals Gregori, Iruzubieta Paula, Lalana Marta, Leis Alba, López Rosa María, Crespo Javier, Morales-Ruiz Manuel |
---|---|
Format: | article |
Langue: | EN ES |
Publié: |
De Gruyter
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4e33d0f9576b45d187bf542aad328304 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
par: T. E. Promenasheva, et autres
Publié: (2014) -
Autophagy: a new target for nonalcoholic fatty liver disease therapy
par: Mao YQ, et autres
Publié: (2016) -
Measurement and clinical usefulness of bilirubin in liver disease
par: Guerra Ruiz Armando Raúl, et autres
Publié: (2021) -
Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis
par: Hsien-Jung Chan, et autres
Publié: (2021) -
Valoración bioquímica en la enfermedad hepática grasa asociada a la disfunción metabólica
par: Guerra-Ruiz Armando R., et autres
Publié: (2021)